4-Phosphopantetheinyl transferases (PPTs) catalyze the transfer of 4-phosphopantetheine (4-PP) from coenzyme A to a conserved serine residue of their protein substrates. In humans, the number of pathways utilizing the 4-PP posttranslational modification is limited and may only require a single broad specificity PPT for all phosphopantetheinylation reactions. Recently, we have shown that one of the enzymes of folate metabolism, 10-formyltetrahydrofolate dehydrogenase (FDH), requires a 4-PP prosthetic group for catalysis. This moiety acts as a swinging arm to couple the activities of the two catalytic domains of FDH and allows the conversion of 10-formyltetrahydrofolate to tetrahydrofolate and CO 2 . In the current study, we demonstrate that the broad specificity human PPT converts apo-FDH to holoenzyme and thus activates FDH catalysis. Silencing PPT by small interfering RNA in A549 cells prevents FDH modification, indicating the lack of alternative enzymes capable of accomplishing this transferase reaction. Interestingly, PPT-silenced cells demonstrate significantly reduced proliferation and undergo strong G 1 arrest, suggesting that the enzymatic function of PPT is essential and nonredundant. Our study identifies human PPT as the FDH-modifying enzyme and supports the hypothesis that mammals utilize a single enzyme for all phosphopantetheinylation reactions.Folate derivatives function as coenzymes in reactions involving the transfer of one-carbon units and participate in key metabolic processes, including nucleotide biosynthesis and the regeneration of methionine from homocysteine (1). The intracellular folate pool consists of several major reduced folate forms, and the overall balance between different folates is maintained by numerous enzymes that incorporate one-carbon groups into the pool, convert these groups within the pool, or utilize them in biosynthetic reactions. One of the folate enzymes, 10-formyltetrahydrofolate (10-fTHF) 2 dehydrogenase (FDH, aldehyde dehydrogenase 1L1, EC 1.5.1.6), oxidizes the formyl group of 10-fTHF to yield tetrahydrofolate (THF) and CO 2 . This reaction requires NADP ϩ and proceeds through a complex multistep mechanism (2). FDH is expressed in most tissues and is particularly abundant in the liver and kidney; in the former it is present at the level of about 1% of the total soluble cytosolic protein (3).The FDH substrate, 10-fTHF, is used as a formyl group donor in two steps of de novo purine biosynthesis (4, 5). The excess of 10-fTHF, not required for this pathway, can be utilized by FDH to replenish the THF pool, thus making folate available for other reactions of one-carbon metabolism. It has been proposed that the FDH reaction serves as a regulator of intracellular purine levels, preventing the excessive flux of one-carbon groups into this pathway (6). Several other metabolic functions have also been attributed to FDH, including storage of intracellular folate in the form of THF (7); detoxification of intracellular formic acid by removing it as CO 2 (8); and regulation of o...